Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141–3148. https://doi.org/10.1210/jc.2009-2670

Article  CAS  PubMed  Google Scholar 

Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85(2):526–529. https://doi.org/10.1210/jcem.85.2.6363

Article  CAS  PubMed  Google Scholar 

Kanakis GA, Chrisoulidou A, Bargiota A, Efstathiadou ZA, Papanastasiou L, Theodoropoulou A, Tigas SK, Vassiliadi DA, Tsagarakis S, Alevizaki M (2016) The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 5(5):681–688. https://doi.org/10.1111/cen.13129

Article  CAS  Google Scholar 

Kinoshita Y, Tominaga A, Usui S, Arita K, Sakoguchi T, Sugiyama K, Kurisu K (2016) Clinical features and natural course of acromegaly in patients with discordance in the nadir GH level on the oral glucose test and the IGF-1 value at 3 months after adenomectomy. Neurosurg Rev 39(2):313–318. https://doi.org/10.1007/s10143-015-0692-5

Article  PubMed  Google Scholar 

Peixe C, Sánchez-García M, Grossman AB, Korbonits M, Marques P (2022) Biochemical discrepancies in the evaluation of the somatotroph axis: elevated GH or IGF-1 levels do not always diagnose acromegaly. Growth Horm IGF Res 64:101467. https://doi.org/10.1016/j.ghir.2022.101467

Article  CAS  PubMed  Google Scholar 

Zhang S, Li Y, Guo X, Gao L, Lian W, Yao Y, Feng M, Bao X, Wang R, Xing B (2018) Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly. J Formos Med Assoc 117(1):34–41. https://doi.org/10.1016/j.jfma.2017.02.014

Article  CAS  PubMed  Google Scholar 

Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S Acromegaly Consensus Group 82024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7–22. https://doi.org/10.1007/s11102-023-01360-1

Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, Hizuka N, Teramoto A, Tatsumi KI, Tachibana K, Katsumata N, Horikawa R (2012) Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J 59(9):771–780. https://doi.org/10.1507/endocrj.ej12-0110

Article  CAS  PubMed  Google Scholar 

Katsumata N, Shimatsu A, Tachibana K, Hizuka N, Horikawa R, Yokoya S, Tatsumi KI, Mochizuki T, Anzo M, Tanaka T (2016) Continuing efforts to standardize measured serum growth hormone values in Japan. Endocr J 63(10):933–936. https://doi.org/10.1507/endocrj.EJ16-0198

Article  CAS  PubMed  Google Scholar 

Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary-adenomas with invasion of the cavernous sinus space - a magnetic-resonance-imaging classification compared with surgical findings. Neurosurg 33(4):610–618. https://doi.org/10.1227/00006123-199310000-00008

Article  CAS  Google Scholar 

Campana C, Cocchiara F, Corica G, Nista F, Arvigo M, Amarù J, Rossi DC, Zona G, Ferone D, Gatto F (2021) Discordant GH and IGF-1 results in treated acromegaly: impact of GH cutoffs and mean values assessment. J Clin Endocrinol Metab 106(3):789–801. https://doi.org/10.1210/clinem/dgaa859

Article  PubMed  Google Scholar 

Elias PC, Lugao HB, Pereira MC, Machado HR, Castro M, Moreira AC (2010) Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity. Horm Metab Res 42(1):50–55. https://doi.org/10.1055/s-0029-1239522

Article  CAS  PubMed  Google Scholar 

Alexopoulou O, Bex M, Abs R, T’Sjoen G, Velkeniers B, Maiter D (2008) Divergence between growth hormone and insulin-like growth factor-I concentrations in the follow-up of acromegaly. J Clin Endocrinol Metab 93(4):1324–1330. https://doi.org/10.1210/jc.2007-2104

Article  CAS  PubMed  Google Scholar 

Freda PU (2009) Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin Endocrinol 71(2):166–170. https://doi.org/10.1111/j.1365-2265.2009.03556.x

Article  CAS  Google Scholar 

Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD (2004) Significance of abnormal nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. J Clin Endocrinol Metab. 2004;89(2):495–500. https://doi.org/10.1210/jc.2003-031316

Asha MJ, Takami H, Velasquez C, Oswari S, Almeida JP, Zadeh G, Gentili F (2020) Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: single-center results. J Neurosurg. 2020;133(5):1360–1370. https://doi.org/10.3171/2019.6.JNS191187

van den Berg G, Veldhuis JD, Frölich M, Roelfsema F (1996) An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 81(7):2460–2467. https://doi.org/10.1210/jcem.81.7.8675561

Article  PubMed  Google Scholar 

Span JP, Pieters GF, Sweep CG, Hermus AR, Smals AG (2000) Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. J Clin Endocrinol Metab 85(3):1121–1125. https://doi.org/10.1210/jcem.85.3.6463

Article  CAS  PubMed  Google Scholar 

Dal J, Rosendal C, Karmisholt J, Feldt-Rasmussen U, Andersen MS, Klose M, Feltoft C, Heck A, Nielsen EH, Jørgensen JOL (2023) Sex difference in patients with controlled acromegaly-a multicentre survey. Clin Endocrinol (Oxf) 98(1):74–81. https://doi.org/10.1111/cen.14750

Article  CAS  PubMed  Google Scholar 

Dal J, Skov BG, Andersen M, Feldt-Rasmussen U, Feltoft CL, Karmisholt J, Nielsen EH, Dekkers OM, Jørgensen JOL (2021) Sex differences in acromegaly at diagnosis: a nationwide cohort study and meta-analysis of the literature. Clin Endocrinol (Oxf) 94(4):625–635. https://doi.org/10.1111/cen.14392

Article  CAS  PubMed  Google Scholar 

Parkinson C, Ryder WD, Trainer PJ (2001) The relationship between serum GH and serum IGF-I in acromegaly is gender-specific. J Clin Endocrinol Metab 86(11):5240–5244. https://doi.org/10.1210/jcem.86.11.8006

Article  CAS  PubMed  Google Scholar 

Birzniece V, Ho KKY (2017) Sex steroids and the GH axis: implications for the management of hypopituitarism. Best Pract Res Clin Endocrinol Metab 31(1):59–69. https://doi.org/10.1016/j.beem.2017.03.003

Article  CAS  PubMed  Google Scholar 

Birzniece V, Sutanto S, Ho KK (2012) Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators. J Clin Endocrinol Metab 97(4):E521–527. https://doi.org/10.1210/jc.2011-3347

Article  CAS  PubMed  Google Scholar 

Meinhardt UJ, Ho KK (2006) Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf) 65(4):413–422. https://doi.org/10.1111/j.1365-2265.2006.02676.x

Article  CAS  PubMed  Google Scholar 

Amodru V, Petrossians P, Colao A, Delemer B, Maione L, Neggers SJCM, Decoudier B, Kamenicky P, Castinetti F, Hana V, Pivonello R, Carvalho D, Brue T, Beckers A, Chanson P, Cuny T (2020) Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database. Endocrine 70(1):134–142. https://doi.org/10.1007/s12020-020-02387-1

Article  CAS  PubMed  Google Scholar